Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer's disease: A systematic review

Raiana Lídice Mór Fukushima, Elisangela Gisele do Carmo, Renata do Valle Pedroso, Pollyanna Natalia Micali, Paula Secomandi Donadelli, Gilson Fuzaro Junior, Reisa Cristiane de Paula Venancio, Juliana Viola, José Luiz Riani Costa, Raiana Lídice Mór Fukushima, Elisangela Gisele do Carmo, Renata do Valle Pedroso, Pollyanna Natalia Micali, Paula Secomandi Donadelli, Gilson Fuzaro Junior, Reisa Cristiane de Paula Venancio, Juliana Viola, José Luiz Riani Costa

Abstract

Introduction: Neuropsychiatric symptoms are frequent in Alzheimer's disease and negatively affect patient quality of life.

Objective: To assess the effectiveness of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease.

Methods: The included articles were reviewed between December 2015 and June 2016, and the inclusion criteria were: (1) studies involving older adults diagnosed with Alzheimer's disease; (2) studies published in English, Spanish or Portuguese; (3) studies that determined the effect of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease; (4) controlled trials.

Results: Out of the total 722, 9 articles matched the inclusion criteria. Depression, apathy and anxiety were the most frequent symptoms.

Conclusion: Studies reported significant results post-treatment, suggesting cognitive stimulation can be effective for these neuropsychiatric symptoms, thus improving the quality of life of Alzheimer's disease patients and their caregivers.

Keywords: Alzheimer's disease; anxiety; apathy; cognitive stimulation; dementia; depression.

Conflict of interest statement

Disclosure: The authors report no conflicts of interest.

Figures

Figure 1. Flowchart illustrating the different phases…
Figure 1. Flowchart illustrating the different phases of search and study selection

References

    1. World Health Organization . Active Ageing: a policy framework. 2005. 2016.
    1. Alzheimer's Disease International . Media quick facts: the global impact of dementia. 2015.
    1. World Health Organization . Mental and behavioral disorders: organic, symptomatic, and mental disorders. 2009.
    1. Yulli N, Hollis V. A systematic review of cognitive stimulation therapy for older adults with mild to moderate dementia an occupational therapy perspective. Occup Ther Int. 2010;18:163–186.
    1. Lyketsos C, Carrilo M, Ryan J. Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement. 2011;7:532–539.
    1. Novak M, Campbell L. Aging and society: a Canadian perspective. 5. ON: Nelson; 2006.
    1. Zhao Q, Tan L, Wang H. The prevalence of neuropsychiatric symptoms in Alzheimer's disease Systematic review and meta-analysis. J Affect Disord. 2016;190:264–271.
    1. Steffens D, Maytan M, Helms M, Plassman B. Prevalence and clinical correlates of neuropsychiatric symptoms in dementia. Am J Alzheimers Dis Other Demen. 2005;20:367–373.
    1. Lyketsos C, Lopez O, Jones B, Fitzpatrick A, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment results from the cardiovascular health study. JAMA. 2002;288:1475–1483.
    1. Grillo R, Mangone C. Perfil de personalidad premórbida en pacientes con demencia tipo Alzheimer presintomaáticos y pacientes con deterioro cognitive vascular no demencial ¿ Es un factor de riesgo ? Neurología Argentina. 2010;2:14–20.
    1. Alzheimer's Disease International . World Alzheimer Report 2015. The Global Impact of Dementia-An Analysis of Prevalence, Incidence, Cost and Trends. London: Alzheimer's Disease International; 2015.
    1. Atri A. Effective pharmacological management of Alzheimer's disease. Am J Manag Care. 2011;17(13):S346–S355.
    1. Matsuda O. Cognitive stimulation therapy for Alzheimer's disease the effect of cognitive stimulation therapy on the progressive of mild Alzheimer's disease in patients treated with donepezil. International Psychogeriatric. 2007;19:241–252.
    1. Woods B, Thorgrimsen I, Spector A, Royan L, Orrel M. Improved quality of life and cognitive stimulation therapy in dementia. Aging and Mental Health. 2006;10:219–226.
    1. Chapman S, Weiner M, Rackley A, Hynan L, Zientz J. Effects of cognitive communication stimulation for. Alzheimer's disease patients treated with donepezil. 2004;47:1149–1163.
    1. Orrel M, Spector A, Thorgrimsen I, Woods B. A pilot study examining the effectiveness of maintenance cognitive stimulation therapy (MCST) for people with dementia. Int J Geriatr Psychiatry. 2005;20:446–451.
    1. Spector A, Davies S, Woods B. Can reality orientation be rehabilitated Development and piloting of an evidence-based programme of cognitive-based therapies for people with dementia. Neuropsychological Rehabilitation. 2001;11:377–397.
    1. Tardif S, Simard M. Cognitive Stimulation Programs in Healthy Elderly A Review. Int J Alzheimers Dis. 2011;2011:1–13.
    1. Woods B, Aguirre E, Spector A, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;15:CD005562–CD005562.
    1. Castel A, Lluch C, Ribas J, Borras L, Molto E. Effects of a cognitive stimulation program on psychological well-being in a sample of elderly long term care hospital in patients. Aging Ment Health. 2015;23:1–7.
    1. D'Onofrio G, Sancarlo D, Addante F. A pilor randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2015;30:965–975.
    1. Azcurra DJLS. A reminiscence program intervention to improve the quality of life of long-term care residents with Alzheimer's disease A randomized controlled trial. Rev Bras Psiquiatr. 2012;34:422–433.
    1. Farina E, Mantovani F, Fioravanti R. Evaluating two group programmes of cognitive training in mild-to-moderate AD is there any difference between a "global" stimulation and a "cognitive-specific" one? Aging Ment Health. 2006;10(3):211–218.
    1. Kim H, Yang Y, Oh J. Effectiveness of a community-based multidomain cognitive intervention program in patients with Alzheimer's disease. Geriatr Gerontol Int. 2016;16(2):191–199.
    1. Maci T, Pira FL, Quattrocchi G, Nuovo D, Perciavalle V, Zappia M. Physical and cognitive stimulation in Alzheimer disease The GAIA Project: a pilot study. Am J Alzheimers Dis Other Demen. 2012;27(2):107–113.
    1. Viola LF, Nunes PV, Yassuda MS. Effects of a multidisciplinar cognitive rehabilitation program for patients with mild Alzheimer's disease. Clinics. 2011;66:1395–1400.
    1. Hattori H, Hattori C, Hokao C, Mizushima K, Mase T. Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients. Geriatr Gerontol Int. 2011;11:431–437.
    1. Niu Y, Tan J, Guan J, Zhang Z, Wang L. Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease a randomized controlled trial. Clin Rehabil. 2010;24(12):1102–1111.
    1. Farina E, Mantovani F, Fioravanti R. Efficacy of recreational and occupational activities associated to psychologic support in mild to moderate Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20:275–282.
    1. Lourenço R, Paradela E. Freitas E, PY L. Tratado de Geriatria e Gerontologia. Rio de Janeiro: Guanabara Koogan; 2011. Instrumentos de avaliação em Geriatria; pp. 979–984.

Source: PubMed

3
Tilaa